Conference Coverage

VA Looks to Increase Real-World Impact of Clinical Research


 

In a separate presentation, Krissa Caroff, MS, CPC, program manager of the Partnered Research Program, said it had quickened the process of implementing clinical trials by tackling roadblocks such as the need for multiple master agreements to be signed. Central coordination has been key, she said, “and we are working closely to ensure that we when have a multisite trial, all the VA sites are utilizing the same single IRB [institutional review board]. We’ve also identified the critical information that we need to collect from industry in order for us to evaluate a trial.”

What’s next? “We really are going to be focusing on oncology trials,” Ramoni insisted. “This is a high priority for us.” She added: “Please share your feedback and experiences with us. And also please communicate amongst your colleagues within your organization to explain how we’re standardizing things within VA.”

The speakers reported no relevant disclosures.

Pages

Recommended Reading

Central Texas Veterans Health Care System’s Experiences With Hematology Oncology Clinical Trials
AVAHO
Effective Pain Control With Very Low Dose Palliative Radiotherapy for Multiple Myeloma Patients With Osseous Lesions
AVAHO
Hemolytic Anemia Secondary to Methylene Blue Administration in a G6PD Sufficient Patient
AVAHO
In-Depth Look at a Community- Based Population of Multiple Myeloma (MM) Patients Undergoing an in-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib in the United States (US) MM-6 Study
AVAHO
Short Story Clubs to Decrease Burnout
AVAHO
The Effect of Treatment Facility and Race on Survival for Signet Ring Cell Carcinoma of the Esophagus: An Analysis of the National Cancer Database
AVAHO
The Vaping Epidemic: Implications for Cancer Care
AVAHO
Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)
AVAHO
August 2020 Advances in Precision Oncology
AVAHO
2020 Cancer Data Trends
AVAHO